E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 12/1/2005 in the Prospect News Biotech Daily.

SFBC maintained by Jefferies at hold

SFBC International Inc. was maintained by Jefferies & Co. Inc. at a hold rating after building inspectors raised structural safety concerns due to Hurricane Wilma at the Miami headquarters, which houses phase 1 clinical operations, the central lab and a screening clinical lab. Jefferies said the company's near-term outlook is cloudy. Shares of the Miami drug development company were down $5.45, or 25.84%, at $15.64 on volume of 11,458,538 shares versus the three-month running average of 836,935 shares.


© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.